Pinnacle Wealth Management Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Buy |
43,459
+333
| +0.8% | +$8.71K | 0.06% | 179 |
|
|
2026
Q1 | $1.21M | Sell |
43,126
-18,211
| -30% | -$485K | 0.08% | 160 |
|
|
2025
Q4 | $1.53M | Sell |
61,337
-4,538
| -7% | -$114K | 0.11% | 129 |
|
|
2025
Q3 | $1.68M | Sell |
65,875
-409
| -0.6% | -$10.1K | 0.13% | 113 |
|
|
2025
Q2 | $1.61M | Buy |
66,284
+693
| +1% | +$16.2K | 0.13% | 109 |
|
|
2025
Q1 | $1.66M | Buy |
65,591
+610
| +0.9% | +$16K | 0.16% | 104 |
|
|
2024
Q4 | $1.72M | Sell |
64,981
-22,623
| -26% | -$614K | 0.16% | 100 |
|
|
2024
Q3 | $2.54M | Sell |
87,604
-6,571
| -7% | -$192K | 0.24% | 84 |
|
|
2024
Q2 | $2.64M | Sell |
94,175
-4,101
| -4% | -$113K | 0.27% | 80 |
|
|
2024
Q1 | $2.73M | Sell |
98,276
-6,866
| -7% | -$191K | 0.29% | 77 |
|
|
2023
Q4 | $3.03M | Sell |
105,142
-17,831
| -14% | -$539K | 0.35% | 67 |
|
|
2023
Q3 | $4.08M | Buy |
122,973
+3,683
| +3% | +$130K | 0.53% | 46 |
|
|
2023
Q2 | $4.38M | Buy |
119,290
+15,937
| +15% | +$620K | 0.54% | 46 |
|
|
2023
Q1 | $4.22M | Sell |
103,353
-17,100
| -14% | -$739K | 0.57% | 45 |
|
|
2022
Q4 | $6.17M | Buy |
120,453
+10,757
| +10% | +$516K | 0.93% | 26 |
|
|
2022
Q3 | $4.8M | Sell |
109,696
-8,071
| -7% | -$392K | 0.8% | 30 |
|
|
2022
Q2 | $6.17M | Sell |
117,767
-2,176
| -2% | -$111K | 1% | 23 |
|
|
2022
Q1 | $6.21M | Buy |
119,943
+15,973
| +15% | +$829K | 0.89% | 24 |
|
|
2021
Q4 | $6.14M | Buy |
103,970
+22,236
| +27% | +$1.1M | 1% | 24 |
|
|
2021
Q3 | $3.52M | Buy |
81,734
+1,264
| +2% | +$56K | 0.82% | 30 |
|
|
2021
Q2 | $3.15M | Buy |
80,470
+10,340
| +15% | +$402K | 0.74% | 33 |
|
|
2021
Q1 | $2.54M | Buy |
70,130
+4,019
| +6% | +$143K | 0.71% | 34 |
|
|
2020
Q4 | $2.43M | Buy |
66,111
+1,370
| +2% | +$50.3K | 0.74% | 32 |
|
|
2020
Q3 | $2.25M | Buy |
64,741
+5,847
| +10% | +$205K | 0.78% | 30 |
|
|
2020
Q2 | $1.83M | Buy |
58,894
+10,664
| +22% | +$362K | 0.68% | 37 |
|
|
2020
Q1 | $1.49M | Buy |
48,230
+6,922
| +17% | +$236K | 0.73% | 35 |
|
|
2019
Q4 | $1.54M | Sell |
41,308
-3,891
| -9% | -$139K | 0.57% | 49 |
|
|
2019
Q3 | $1.54M | Buy |
45,199
+362
| +0.8% | +$13.2K | 0.65% | 44 |
|
|
2019
Q2 | $1.84M | Buy |
44,837
+2,732
| +6% | +$108K | 0.78% | 34 |
|
|
2019
Q1 | $1.7M | Buy |
42,105
+1,919
| +5% | +$76.9K | 0.77% | 36 |
|
|
2018
Q4 | $1.66M | Buy |
40,186
+83
| +0.2% | +$3.45K | 0.9% | 30 |
|
|
2018
Q3 | $1.68M | Buy |
40,103
+4,440
| +12% | +$171K | 0.83% | 32 |
|
|
2018
Q2 | $1.23M | Sell |
35,663
-2,149
| -6% | -$73.4K | 0.66% | 44 |
|
|
2018
Q1 | $1.27M | Sell |
37,812
-141
| -0.4% | -$4.85K | 0.72% | 41 |
|
|
2017
Q4 | $1.3M | Sell |
37,953
-1,127
| -3% | -$38.4K | 0.72% | 43 |
|
|
2017
Q3 | $1.32M | Sell |
39,080
-975
| -2% | -$31.3K | 0.77% | 37 |
|
|
2017
Q2 | $1.28M | Buy |
40,055
+2,553
| +7% | +$80.5K | 0.79% | 39 |
|
|
2017
Q1 | $1.22M | Sell |
37,502
-1,580
| -4% | -$49.8K | 0.84% | 38 |
|
|
2016
Q4 | $1.2M | Buy |
39,082
+4,013
| +11% | +$123K | 0.86% | 35 |
|
|
2016
Q3 | $1.13M | Sell |
35,069
-446
| -1% | -$14.9K | 0.85% | 34 |
|
|
2016
Q2 | $1.19M | Buy |
35,515
+1,423
| +4% | +$45.4K | 0.94% | 32 |
|
|
2016
Q1 | $959K | Buy |
34,092
+1,683
| +5% | +$48.1K | 0.85% | 43 |
|
|
2015
Q4 | $993K | Buy |
32,409
+848
| +3% | +$26.7K | 0.91% | 36 |
|
|
2015
Q3 | $941K | Buy |
31,561
+975
| +3% | +$31.3K | 0.91% | 36 |
|
|
2015
Q2 | $973K | Buy |
30,586
+516
| +2% | +$16.8K | 0.9% | 35 |
|
|
2015
Q1 | $993K | Buy |
30,070
+29
| +0.1% | +$922 | 0.89% | 36 |
|
|
2014
Q4 | $888K | Buy |
+30,041
| New | +$861K | 0.83% | 42 |
|
Other funds holding PFE
Pinnacle Wealth Management Advisory Group's PFE Position: Q2 2026 in Review
Pinnacle Wealth Management Advisory Group increased its Pfizer (PFE) stake by 0.77% in Q2 2026, buying an estimated $8.71K and bringing the position to 43,459 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #179.
Pinnacle Wealth Management Advisory Group first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $6.21M in Q1 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pinnacle Wealth Management Advisory Group held 43,459 shares of Pfizer worth $1.05M as of Q2 2026.
- Pinnacle Wealth Management Advisory Group bought 333 Pfizer shares in Q2 2026, an estimated $8.71K.
- Pfizer made up 0.06% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #179 holding.
- Pinnacle Wealth Management Advisory Group first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Pinnacle Wealth Management Advisory Group's Pfizer position peaked at $6.21M in Q1 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.